Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II trial of TLC-599 for osteoarthritis pain meets primary and key secondary endpoints

Aug. 21, 2018

Japanese approval for Tagrisso as first-line treatment of EGFR-mutated NSCLC

Aug. 21, 2018

New Rho kinase inhibitors described by Chiesi Farmaceutici

Aug. 21, 2018

Hanmi Science patents oncolytic compounds

Aug. 21, 2018

Vectura completes pediatric studies with VR-647 for asthma

Aug. 21, 2018

Antiangiogenic compounds synthesized at Celgene

Aug. 21, 2018

Adare Pharmaceuticals describes cysteamine prodrugs

Aug. 21, 2018

Biogen identifies new NRF2 activators

Aug. 21, 2018

Phase III study of MC2-01 cream in psoriasis vulgaris meets primary and secondary endpoints

Aug. 21, 2018

Novo Nordisk reports topline PIONEER 5 results for oral semaglutide

Aug. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...